cancer screening; coverage; gene mutation
HB 2292 mandates Arizona health insurers cover genetic cancer screening for mutation carriers without prior authorization or patient cost-sharing, expanding preventive access.
HB 2292 mandates Arizona health insurers cover genetic cancer screening for mutation carriers without prior authorization or patient cost-sharing, expanding preventive access.
HB 2292 requires health insurance plans in Arizona to cover genetic testing and cancer screening for individuals with identified gene mutations associated with increased cancer risk. The bill mandates coverage without prior authorization requirements or cost-sharing barriers for eligible patients. This applies to both individual and group health insurance policies offered in the state.
Genetic mutations like BRCA1/BRCA2 significantly increase lifetime risk for breast, ovarian, and other cancers, but preventive screening and early detection can substantially improve survival rates. Current insurance practices sometimes restrict or delay coverage for genetic testing and follow-up screening, creating barriers to preventive care. This bill aims to remove financial obstacles for individuals at genetic risk, potentially catching cancers at earlier, more treatable stages.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.